TrialGut microbes2025

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial.

Bas Groenewegen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.